Endocrinol Metab.  2011 Mar;26(1):36-37. 10.3803/EnM.2011.26.1.36.

A Case of Aldosterone-secreting Adrenocortical Carcinoma

• Choi B
• Lee S

• KMID: 2169122
• DOI: http://doi.org/10.3803/EnM.2011.26.1.36

Abstract

No abstract available.

MeSH Terms

Adrenocortical Carcinoma

Figure

• 

  Fig. 1 Abdomino-pelvic computed tomography of abdomen showed 6.4 × 4.2 × 5.7 cm sized lobulating contoured heterogeneous enhancing mass in left suprarenal area.

• 

  Fig. 2 Microscopic findings of the tumor show vascular tumor invasion (H&E staining, × 200) (A), and marked nuclear pleomorphism (H&E staining, × 400) (B).

Reference

1. Kronenberg HM, Melmed S, Polonsky KS, Larsen PR. Williams textbook of endocrinology. 2008. 11th ed. Philadelphia: Saunders Elsevier.

2. Weiss LM, Medeiros LJ, Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. Am J Surg Pathol. 1989. 13:202–206.

3. Sasano H, Suzuki T, Moriya T. Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma. Endocr Pathol. 2006. 17:345–354.

4. Fassnacht M, Allolio B. Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab. 2009. 23:273–289.

5. Stojadinovic A, Ghossein RA, Hoos A, Nissan A, Marshall D, Dudas M, BCordon-Cardo C, Jaques DP, Brennan MF. Adrenocortical carcinoma: clinical, morphologic, and molecular characterization. J Clin Oncol. 2002. 20:941–950.

6. Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, Rossetto R, Buci L, Sperone P, Grossrubatscher E, Reimondo G, Bollito E, Papotti M, Saeger W, Hahner S, Koschker AC, Arvat E, Ambrosi B, Loli P, Lombardi G, Mannelli M, Bruzzi P, Mantero F, Allolio B, Dogliotti L, Berruti A. Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med. 2007. 356:2372–2380.